Treatment Advances in Locally Advanced and Metastatic Non-Small Cell Lung Cancer
Year: 2010
Type: dissertation
Abstract: Lung cancer is the leading cause of cancer mortality in the United States and Europe.\nApproximately 85% of the patients with lung cancer have non–small cell lung cancer\n(NSCLC), which can be classified into squamous, adeno, large cell and not otherwise\nspecified (NOS) histologies. The most common histologies are: adenocarcinoma ( 50%),\nsquamous cell ( 20%), and large cell ( 10%). More than two third of the patients\nhave locally advanced or metastatic disease at the time of diagnosis.
Author: Veerle Surmont
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1550758729